Documents
Application Sponsors
Marketing Status
Application Products
| 001 | SUPPOSITORY;RECTAL | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | 1 | ROWASA | MESALAMINE |
FDA Submissions
| TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1990-12-18 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1997-08-08 | STANDARD |
| LABELING; Labeling | SUPPL | 4 | AP | 2001-10-01 | STANDARD |
Submissions Property Types
| ORIG | 1 | Null | 0 |
| SUPPL | 2 | Null | 0 |
| SUPPL | 4 | Null | 0 |
CDER Filings
MEDA PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 19919
[companyName] => MEDA PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"ROWASA","activeIngredients":"MESALAMINE","strength":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","dosageForm":"SUPPOSITORY;RECTAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"Yes"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ROWASA","submission":"MESALAMINE","actionType":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","submissionClassification":"SUPPOSITORY;RECTAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)